Dr. Sreekala Raghavan, MD

Dr. Raghavan practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Raghavan's NPI, 1184912578, was assigned on July 19, 2011. Dr. Raghavan holds New York license 270371.

Dr. Raghavan's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Raghavan also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Raghavan's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. Dr. Raghavan is also affiliated with Mount Sinai Beth Israel. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Raghavan to 1 more hospital, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Raghavan practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Raghavan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Raghavan is licensed in New York.

CMS data shows 50 Medicare services from Dr. Raghavan across 1 procedure code in 2024, all of them office visits, for 53 Medicare patients. Medicare paid $3,832 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 53 Medicare patients who saw Dr. Raghavan in 2024. The largest group is 65 to 74, with 25 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Raghavan's median patient age at 63, with 64% women.

In 2024, Dr. Raghavan wrote 1,764 Medicare Part D claims for 434 patients. 80% of them were for generic drugs. CMS names the drug for 1,200 of them, across 37 drugs with 11 or more claims each, at $150,212 in total drug cost. In 2023, CMS named 933 claims across 33 drugs.

Dr. Raghavan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Raghavan from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $20.